vimarsana.com
Home
Live Updates
Immunic, Inc. (NASDAQ:IMUX) Q4 2023 Earnings Call Transcript
Immunic, Inc. (NASDAQ:IMUX) Q4 2023 Earnings Call Transcript
Immunic, Inc. (NASDAQ:IMUX) Q4 2023 Earnings Call Transcript
Immunic, Inc. beats earnings expectations. Reported EPS is $-0.48, expectations were $-0.51.
Related Keywords
United States ,
Amsterdam ,
Noord Holland ,
Netherlands ,
Athens ,
Attikír ,
Greece ,
America ,
Geertr Dhaens ,
Franziska Burianek ,
Bob Fox ,
Daniel Vitt ,
Jessica Breu ,
Glenn Whaley ,
Nasdaq ,
Immunic Inc ,
Assembly Conference ,
Association Of European Celiac Society ,
Amsterdam University Medical Center ,
Call Transcript February ,
Fourth Quarter ,
Year End ,
Vice President ,
Investor Relations ,
Chief Executive Officer ,
Chief Financial ,
Avidity Partners ,
Janus Henderson Investors ,
Soleus Capital ,
Adage Capital ,
Paying Jobs ,
Visited Countries ,
Cleveland Clinic ,
United European Gastroenterology Week ,
Senior Medical Director ,